These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 19199188

  • 1. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI, Anzueto A.
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [Abstract] [Full Text] [Related]

  • 2. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.
    Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, Carratalà J.
    Clin Microbiol Infect; 2011 Nov; 17(11):1659-65. PubMed ID: 21463391
    [Abstract] [Full Text] [Related]

  • 3. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
    Falcone M, Venditti M, Shindo Y, Kollef MH.
    Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
    [Abstract] [Full Text] [Related]

  • 4. What is healthcare-associated pneumonia and how is it managed?
    Carratalà J, Garcia-Vidal C.
    Curr Opin Infect Dis; 2008 Apr; 21(2):168-73. PubMed ID: 18317041
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P, Lorsutthitham J, Ungprasert P, Angkasekwinai N, Thamlikitkul V.
    J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
    [Abstract] [Full Text] [Related]

  • 6. What is healthcare-associated pneumonia, and how should it be treated?
    Craven DE.
    Curr Opin Infect Dis; 2006 Apr; 19(2):153-60. PubMed ID: 16514340
    [Abstract] [Full Text] [Related]

  • 7. Gram-negative bacterial pneumonia: aetiology and management.
    Koulenti D, Rello J.
    Curr Opin Pulm Med; 2006 May; 12(3):198-204. PubMed ID: 16582675
    [Abstract] [Full Text] [Related]

  • 8. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
    Martínez B, Gómez J, Gómez Vargas J, Gómez JR, Baños V, Sánchez ME, Canteras M, Valdés M.
    Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
    [Abstract] [Full Text] [Related]

  • 9. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
    Kunz AN, Brook I.
    Chemotherapy; 2010 Jun; 56(6):492-500. PubMed ID: 21099222
    [Abstract] [Full Text] [Related]

  • 10. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D, De Bels D, Forêt F, Cran S, Gilbert E, Schoonheydt K, Blot S, ANTHICUS Study Investigators.
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of healthcare-associated pneumonia (HCAP).
    Zilberberg MD, Shorr AF.
    Semin Respir Crit Care Med; 2009 Feb; 30(1):10-5. PubMed ID: 19199182
    [Abstract] [Full Text] [Related]

  • 12. Current perspective of the HCAP problem: is it CAP or is it HAP?
    Polverino E, Torres A.
    Semin Respir Crit Care Med; 2009 Apr; 30(2):239-48. PubMed ID: 19296421
    [Abstract] [Full Text] [Related]

  • 13. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ, Liu LL, Xiaoli LY, Wang YP, Huang D, Pian HY, Zhu YC.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [Abstract] [Full Text] [Related]

  • 14. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME.
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [Abstract] [Full Text] [Related]

  • 15. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR, Cooke RP, Lal P, Pickles D, Majjid S, Grant CA, Jones TM, Dempsey GA.
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [Abstract] [Full Text] [Related]

  • 16. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A.
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [Abstract] [Full Text] [Related]

  • 17. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS.
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [Abstract] [Full Text] [Related]

  • 18. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    Jones RN.
    Clin Infect Dis; 2010 Aug 01; 51 Suppl 1():S81-7. PubMed ID: 20597676
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital.
    Jeong BH, Koh WJ, Yoo H, Park HY, Suh GY, Chung MP, Kwon OJ, Jeon K.
    Respiration; 2014 Aug 01; 88(3):190-8. PubMed ID: 24994099
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M, Carratalà J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM.
    Respirology; 2009 Jan 01; 14(1):105-11. PubMed ID: 18699803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.